About the Gastrointestinal Stromal Tumors Session
Gastrointestinal stromal tumors (GISTs) present a unique challenge in cancer research due to their rarity and diverse genetic makeup. While GISTs are relatively uncommon compared to other gastrointestinal cancers, they exhibit significant heterogeneity in their molecular characteristics, leading to variations in treatment response and outcomes. Recent advancements in cancer research have unveiled key molecular drivers behind GIST development, such as mutations in the KIT and PDGFRA genes, paving the way for targeted therapies like imatinib. However, resistance to these treatments remains a concern, driving ongoing efforts to elucidate alternative therapeutic strategies and biomarkers for predicting treatment response. Collaborative interdisciplinary approaches combining genomic profiling, immunotherapy, and novel drug development are essential for improving outcomes and addressing the complex nature of GISTs in the realm of cancer research.
Topics Covered in Gastrointestinal Stromal Tumors
KIT & PDGFRA Mutations
Tyrosine Kinase Inhibitors
Secondary Drug Resistance
SDH-Deficient Tumors
Recurrence Risk Scoring
Surgical Resection
Related Scientific Sessions at CIOC 2027
Why Attend the Gastrointestinal Stromal Tumors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Gastrointestinal Stromal Tumors work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Gastrointestinal Stromal Tumors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Gastrointestinal Stromal Tumors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Gastrointestinal Stromal Tumors Conference 2027 — FAQs
What is the Gastrointestinal Stromal Tumors track at CIOC 2027?
The Gastrointestinal Stromal Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Gastrointestinal Stromal Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Gastrointestinal Stromal Tumors sessions?
Cancer researchers and clinicians, educators and students with an interest in Gastrointestinal Stromal Tumors are all welcome — whether presenting or attending.
Can I present my research in the Gastrointestinal Stromal Tumors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Gastrointestinal Stromal Tumors sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Gastrointestinal Stromal Tumors track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.